Cefotaximeisltslowmyco
Key facts at a glance
- LOINC
- 50632-9
- Short code
- CEFOSUS
- Synonyms
- Cefotaxime Islt SlowMyco
- Category
- chemistry
- Sample
- serum
- Container
- Sterile, screw-capped, leak-proof container for clinical specimen (e.g., sputum, tissue, or body fluid). For serum: red-top or serum separator tube (SST).
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- method-for-slow-growing-mycobacteria
- CPT
- 87188
- SNOMED
- 399227001
- Specimen volume
- 1-5 mL of clinical specimen or 1-2 mL serum
- Stability
- Specimen should be processed within 24 hours of collection if held at room temperature. If delay is anticipated, refrigerate at 2-8°C for up to 7 days. For prolonged storage, freeze at -70°C.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 72–336 hours
- Order
- routine
Reference range
Interpretive criteria based on CLSI M24 and M62 guidelines for slow-growing mycobacteria: Susceptible (S), Intermediate (I), or Resistant (R). MIC breakpoints vary by mycobacterial species.N/A
No special patient preparation required. Specimen should be collected prior to administration of antimicrobial agents whenever possible. Patient should not be on ongoing antimicrobial therapy at the time of collection unless clinically indicated.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy